Xenon Pharmaceuticals Inc (XENE) Financials
Key financial figures for Xenon Pharmaceuticals Inc (Q2 2026).
- Revenue
- $0
- Net Income
- -$111M
- EPS
- $-1.11
- Total Assets
- $1.3B
- Operating Cash Flow
- -$95M
Full income statement, balance sheet, and cash flow for Xenon Pharmaceuticals Inc on SentiSense.